Cargando…
Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?
Unpredictable treatment responses have been an obstacle for the successful management of rheumatoid arthritis. Although numerous serum proteins have been proposed, there is a lack of integrative survey to compare their relevance in predicting treatment outcomes in rheumatoid arthritis. Also, little...
Autores principales: | Chen, Shuo-Fu, Yeh, Fu-Chiang, Chen, Ching-Yun, Chang, Hui-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257292/ https://www.ncbi.nlm.nih.gov/pubmed/37301840 http://dx.doi.org/10.1186/s12014-023-09411-2 |
Ejemplares similares
-
When to start and when to stop antifibrotic therapies
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2017) -
The increased cardiovascular risk in rheumatoid arthritis: when does it start?
por: Nurmohamed, Michael T
Publicado: (2010) -
Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?
por: Tracy, Alexander, et al.
Publicado: (2017) -
Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
por: Lee, J.J.X., et al.
Publicado: (2021) -
Stopping screening, when and how?
por: Hugosson, Jonas
Publicado: (2018)